---
title: "AXA posts report following 2026 half-year results webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294395545.md"
description: "AXA published its first-half 2026 results release on July 31, 2026. A full report and a podcast replay of the half-year results webcast are available online."
datetime: "2026-07-30T16:51:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294395545.md)
  - [en](https://longbridge.com/en/news/294395545.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294395545.md)
generator: "portal-rs"
---

# AXA posts report following 2026 half-year results webcast

-   AXA published its first-half 2026 results release, dated July 31, 2026. \* Full report posted at here a podcast replay will also be posted there. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AXA SA published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AXAHY.US](https://longbridge.com/en/quote/AXAHY.US.md)

## Related News & Research

- [15:00 ETKerry Vitolano joins AXA XL as Head of East USRM and Head of USRM](https://longbridge.com/en/news/296390727.md)
- [Itera ASA to present preliminary Q2 2026 results via webcast](https://longbridge.com/en/news/296590225.md)
- [Eolus schedules webcast, teleconference to present Q2 interim report](https://longbridge.com/en/news/296458713.md)
- [Frontline schedules Q2 2026 results webcast and conference call](https://longbridge.com/en/news/296622834.md)
- [Lytix Biopharma to webcast Q2 2026 results presentation](https://longbridge.com/en/news/296571638.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**